What will have a bigger impact upon Medicare & Medicaid than Cancer and Heart Disease? The cost of treating Alzheimer’s disease. According to the Alzheimer’s Association by 2050, Medicare & Medicaid spending on people with Alzheimer’s will increase by 278% from today’s spending levels*. In recent years, scientists have made great progress in understanding Alzheimer’s. These scientists, with Life Science Project Managers by their side, are developing and testing new treatments, including recently approved and others in late-stage clinical trials. None of these treatments are indicated to cure Alzheimer’s but rather help to manage symptoms and slow progress of the disease for people in the early or middle stages.
Before looking at examples of how Project Managers have become even more involved in Alzheimer’s care, the following is a brief background on Alzheimer’s disease. As per The Economist, “About 115 years ago, Alois Alzheimer, a German psychiatrist, conducted the autopsy of a patient named, Auguste Deter that helped him identify the disease now known as Alzheimer’s. He noticed three unusual features of her brain. It was at least a third smaller than normal. Many neurons, the nerve cells, had vanished. He also saw abnormal deposits inside the remaining cells, especially in the cerebral cortex, the thin outer layer of grey matter. Between a third and a quarter had been invaded by dense knotty bundles, now known as “neurofibrillary tangles”, caused by a build-up of a protein called tau. And across the cortex were deposits of another protein, since identified as beta-amyloid, which collect between neurons and disrupt their functioning”.
Caring for someone with Alzheimer’s requires more than medicines. It involves human beings skilled with deep empathy and endurance leveraging new resources to help redefine care. Consequently, managing cross functional teams on the development of these new care resources is an area for Project Managers to contribute even more. The following are just a few examples of these new care resources.
Finally, to further complicate the already complex and costly Alzheimer’s treatment space, Covid-19 has accelerated the known challenges of care for Alzheimer’s patients across the world as well as creating new ones in the areas of research, outcomes and long-term care facilities.
*Costs of Alzheimer's to Medicare and Medicaid
What to Send: PM related information that would assist Life Science PMs with Leadership, Strategy and Technology. The information can be a short description with the details at an included link. Do not provide advertising related materials.
Where to Send: Submit items of interest to LifeSciencesInfo@pminj.org with a short description.
Review: The information will be reviewed for relevant Life Sciences content for the PM community prior to posting.
PMINJ is not responsible for the content or quality of any posted materials.